Q2 2020 13F Holders as of 30 Jun 2020
-
Type / Class
-
Equity / COM NEW
-
Total 13F shares
-
2,440,539
-
Share change
-
+190,437
-
Total reported value
-
$1,283,000
-
Price per share
-
$0.52
-
Number of holders
-
22
-
Value change
-
+$97,382
-
Number of buys
-
7
-
Number of sells
-
4
Institutional Holders of VISTAGEN THERAPEUTICS INC - COM NEW (VTGN) as of Q2 2020
As of 30 Jun 2020,
VISTAGEN THERAPEUTICS INC - COM NEW (VTGN) was held by
22 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
2,440,539 shares.
The largest 10 holders included
VANGUARD GROUP INC, GEODE CAPITAL MANAGEMENT, LLC, ADVISOR GROUP HOLDINGS, INC., D.A. DAVIDSON & CO., HighTower Advisors, LLC, NORTHERN TRUST CORP, UBS Group AG, JANE STREET GROUP, LLC, Parallax Volatility Advisers, L.P., and Sitrin Capital Management LLC.
This page lists
22
institutional shareholders reporting positions in this security
for the Q2 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.